Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1989 | 12-1988 | 12-1987 | 12-1986 | 12-1985 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,502 | 11,396 | 15,855 | 4,533 | 1,983 |
| Receivables | 329 | 266 | 275 | 71 | 74 |
| Inventories | 150 | 103 | 45 | 129 | 13 |
| Other current assets | 787 | 485 | 354 | 96 | 19 |
| TOTAL | $8,768 | $12,250 | $16,529 | $4,829 | $2,089 |
| Non-Current Assets | |||||
| PPE Net | 4,344 | 4,289 | 4,157 | 4,473 | 638 |
| Other Non-Current Assets | 71 | 278 | 285 | 312 | 25 |
| TOTAL | $4,415 | $4,566 | $4,441 | $4,785 | $663 |
| Total Assets | $13,183 | $16,816 | $20,970 | $9,614 | $2,751 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 254 | 289 | 444 | 420 | 227 |
| Accrued Expenses | 417 | 269 | 112 | 78 | 18 |
| Other current liabilities | 0 | 0 | 22 | 0 | 630 |
| TOTAL | $671 | $558 | $673 | $582 | $884 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,000 | 3,000 | 3,000 | 3,335 | 0 |
| TOTAL | $3,000 | $3,000 | $3,056 | $3,439 | $14 |
| Total Liabilities | $3,671 | $3,558 | $3,729 | $4,021 | $898 |
| Shareholders' Equity | |||||
| Common Shares | 95 | 91 | 87 | 730 | 419 |
| Retained earnings | -19,211 | -14,695 | -9,707 | -5,866 | -2,726 |
| Other shareholders' equity | 32 | 33 | 33 | 10,729 | 4,160 |
| TOTAL | $9,511 | $13,259 | $17,241 | $5,592 | $1,854 |
| Total Liabilities And Equity | $13,183 | $16,817 | $20,970 | $9,614 | $2,751 |